Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Thatcher

Showing results (221-230 of 237) with videos related to

Pageof 24
Sort By:
Journal of Medicinal Chemistry|June 10, 2026
Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPTGanga Reddy Velma, Sandeep Kumar, Piush Srivastava, et al.
Journal of Medicinal Chemistry|August 5, 2024
Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral ActivityGanga Reddy Velma, Zhengnan Shen, Cameron Holberg, et al.
Journal of Medicinal Chemistry|December 14, 2023
Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs)Zhengnan Shen, Kiira Ratia, Isabella Krider, et al.
Molecular Cancer Therapeutics|November 12, 2020
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast CancerBalkees Abderrahman, Philipp Y Maximov, Ramona F Curpan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 7, 2014
SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolitesL P Madhubhani P Hemachandra, Hitisha Patel, R Esala P Chandrasena, et al.
Biochemistry|February 6, 2023
Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD<sup></sup>Kiira M Ratia, Zhengnan Shen, Jesse Gordon-Blake, et al.
ACS Chemical Neuroscience|January 18, 2018
Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 InhibitorsIrina N Gaisina, Sue H Lee, Navneet A Kaidery, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2022
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancerDaniel R Principe, Rui Xiong, Yangfeng Li, et al.
ACS Chemical Biology|May 26, 2018
Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as "Doorstop" for NADPH EntryIlaria Silvestri, Haining Lyu, Francesca Fata, et al.
Frontiers in Cell and Developmental Biology|June 9, 2025
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Pageof 24

Showing results (221-230 of 237) with videos related to

Sort By:
Pageof 24
Journal of Medicinal Chemistry|June 10, 2026
Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPTGanga Reddy Velma, Sandeep Kumar, Piush Srivastava, et al.
Journal of Medicinal Chemistry|August 5, 2024
Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral ActivityGanga Reddy Velma, Zhengnan Shen, Cameron Holberg, et al.
Journal of Medicinal Chemistry|December 14, 2023
Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs)Zhengnan Shen, Kiira Ratia, Isabella Krider, et al.
Molecular Cancer Therapeutics|November 12, 2020
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast CancerBalkees Abderrahman, Philipp Y Maximov, Ramona F Curpan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 7, 2014
SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolitesL P Madhubhani P Hemachandra, Hitisha Patel, R Esala P Chandrasena, et al.
Biochemistry|February 6, 2023
Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD<sup></sup>Kiira M Ratia, Zhengnan Shen, Jesse Gordon-Blake, et al.
ACS Chemical Neuroscience|January 18, 2018
Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 InhibitorsIrina N Gaisina, Sue H Lee, Navneet A Kaidery, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2022
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancerDaniel R Principe, Rui Xiong, Yangfeng Li, et al.
ACS Chemical Biology|May 26, 2018
Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as "Doorstop" for NADPH EntryIlaria Silvestri, Haining Lyu, Francesca Fata, et al.
Frontiers in Cell and Developmental Biology|June 9, 2025
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Pageof 24